A 40-year-old female presented to the emergency department at an outside facility with symptoms of vaginal bleeding, abdominal pain, headaches, dizziness, double vision, and epistaxis. The patient had been experiencing heavy vaginal bleeding with abdominal pain for a period of several months after a normal C-section delivery of a healthy female infant. Her placental pathology revealed a small nodular placental lesion consistent with trophoblastic disease (Fig. 1) .
Radiology Case Reports
Volume 10, Issue 1, 2015 Fig. l. Placental pathology revealed a small (2.5 cm x 2.0 cm x 2.0 cm) nodular placental lesion consistent with trophoblastic disease. Choriocarcinoma is characterized by abnormal trophoblastic hyperplasia and anaplasia (black arrows), absence of chorionic villi, hemorrhage, necrosis (white arrows), and direct invasion into the myometrium. (H&E stain, 100x magnification) nal masses. Due to high suspicion for an ectopic pregnancy, she was taken to the operating room for a diagnostic laparoscopy, which revealed a small hematoma in the retroperitoneum, but no etopic pregnancy. She required multiple blood transfusions, as her hemoglobin had dropped from 11 to 7 g/dL. She also underwent diagnostic CT scans of the chest, abdomen, and pelvis that revealed a right-upperlobe pulmonary lesion, bilateral renal lesions, and an associated left-sided retroperitoneal hematoma (Fig. 2) .
Due to concern for malignant gestational trophoblastic disease with hemorrhage, the patient was transferred to our institution for a higher level of care. She was admitted to the gynecologic-oncology service for further workup and treatment. A pelvic ultrasound revealed no intrauterine pregnancy, no focal mass lesions, normal adnexa, and a thickened endometrium measuring up to 2 cm with a small amount of flow. As part of the metastatic workup, the patient underwent a head CT scan that revealed a 4-mm contrast-enhancing focus in the left parietal lobe. A subsequent MRI demonstrated the solitary lesion, with no other intracranial metastases identified (Fig. 3) . A diagnosis of metastatic gestational trophoblastic neoplasm was made with a WHO score of 14, or Stage IV disease, with renal and brain metastases. The patient was started on induction chemotherapy with etoposide and cisplatin, plus whole brain radiation, and was subsequently discharged. Unfortunately, the patient represented to the emergency department two days later with symptoms of nausea, vomiting, severe abdominal pain radiating to the left flank, and weakness. Her hemoglobin had dropped from 10.0 g/dL on discharge to 8.4 g/dL on readmission to the emergency department. An abdomen/pelvis CT scan revealed increased size of the large left retroperitoneal hematoma and interval development of a new retroperitoneal hematoma (Fig. 4) . The patient was readmitted to the gynecologiconcology service. Due to concern for active bleeding, interventional radiology was consulted for possible embolization. After bilateral renal arteriography, however, no active extravasation or hypervascular tumors were identified, and embolization could not be performed. The patient was managed supportively and remained hemodynamically stable during the subsequent course of her hospitalization and discharged home with a plan to continue on an EMA/ CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine/oncovine) chemotherapy regimen, and whole brain radiation.
Discussion
Gestational trophoblastic disease (GTD) includes a spectrum of abnormalities arising from the placental villous trophoblast and consists of four main types: hydatidiform mole, invasive mole, placental site trophoblastic tumor (PSTT), and choriocarcinoma. Gestational trophoblastic neoplasia (GTN) implies metastatic potential, and refers to the latter three abnormalities, which have a high mortality rate if untreated. Prior to chemotherapy, invasive moles carried a mortality rate of approximately 15%, and choriocarcinoma resulted in a mortality rate of almost 100%. The outcomes of GTN improved drastically after the introduction of chemotherapy, with cure rates of greater than 90% (1-4). There is limited data regarding the incidence of choriocarcinoma due to its rarity and challenging clinical distinction from invasive mole. Choriocarcinoma has an incidence of approximately 1 in 40,000 pregnancies in Europe and North America, and a higher incidence in Southeast Asia and Japan of approximately 9.2 and 3.3 in 40,000 pregnancies. Incidence rates for both hydatidiform mole and choriocarcinoma have declined over the latter part of the 21st century (5, 6) .
Pathologically, choriocarcinoma is characterized by abnormal trophoblastic hyperplasia and anaplasia, absence of chorionic villi, hemorrhage, necrosis, and direct invasion into the myometrium (Fig. 1) (1, 7) . Vascular invasion (hematogenous spread) results in distant metastases that most commonly include the lungs (76%-87%), vagina (30%), brain (10%), liver (10%), pelvis, kidney, intestines, and spleen, although metastases have been reported in virtually every body site (8). It is rare, however, to have additional metastatic sites in the absence of lung metastases (9) . Vaginal metastases are an exception, as spread is contiguous rather than hematogenous (10) . Although metastatic disease has been reported in up to 19% of all GTN, choriocarcinoma accounts for the majority of cases (9) . Central nervous system metastases may produce neurologic symptoms, intracranial hemorrhage, or mass lesions. Biopsy is rarely necessary and may result in excessive bleeding, with serum beta-hCG and exclusion of pregnancy being the main diagnostic criteria required for GTN in the presence of metastases (11) (12) (13) .
Ultrasound is the imaging study of choice for the initial diagnosis of GTN. In addition to identifying a molar pregnancy, ultrasound is primarily used to exclude an intrauterine pregnancy before initiation of chemotherapy. Although transvaginal ultrasound results in greater resolution and can potentially demonstrate more findings, it is not routinely done at all centers due to the risk of bleeding from possible vaginal metastases. Choriocarcinoma is markedly hypervascular on Doppler ultrasonography; however, endometrial, myometrial, and parametrial invasion can be difficult to demonstrate (9) .
Magnetic resonance imaging (MRI) of the pelvis can be helpful in such cases, but it is seldom clinically indicated in the routine assessment of GTN and is typically used in challenging cases such as relapsed patients, suspected PSTT, or very advanced disease. MRI of the brain, however, is recommended for staging, especially in the presence of lung metastases and neurologic symptoms, as these patients are at significant risk for CNS metastases (9, 14, 15) .
Although a chest radiograph is recommended as the initial radiographic staging for patients with malignant GTN, a computed tomography scan (CT) is more routinely performed, as approximately 41% of patients have lung metastases that are not detected on plan radiograph (16) . Contrast-enhanced CT is the diagnostic modality of choice for the assessment of metastatic disease, as choriocarcinoma is characteristically hypervascular and tends to bleed (8, 9) .
As with our patient, choriocarcinoma can be complicated by hemorrhage from the tumor itself or from vascular malformations. GTN is the most common cause of uterine vascular malformations, and when hemorrhage occurs as a complication, the lesions are amenable to endovascular management, as these lesions are supplied by the uterine arteries (17) . Our case, however, resulted in a negative bilateral renal arteriography, which precluded embolization of a self-resolved retroperitoneal bleed.
In summary, choriocarcinoma is a challenging diagnosis to make during a single presentation. Prolonged menorrhagia and markedly elevated beta-hCG should raise suspicion for choriocarcinoma and prompt further workup, especially in the setting of neurologic symptoms. Choriocarcinoma accounts for the majority of metastatic GTN and predominantly demonstrates hematogenous spread. Most common sites of hematogenous metastases include lungs, brain, liver, pelvis, and kidneys. Vaginal metastases are also common and occur via contiguous spread. Biopsy is rarely necessary for diagnosis and can result in excessive bleeding. Urgent specialist consultation with induction of chemotherapy can significantly improve prognosis.
